| Literature DB >> 21666671 |
Rosa La Marca1, Federica Cerri, Keisuke Horiuchi, Angela Bachi, M Laura Feltri, Lawrence Wrabetz, Carl P Blobel, Angelo Quattrini, James L Salzer, Carla Taveggia.
Abstract
Tumor necrosis factor-α-converting enzyme (TACE; also known as ADAM17) is a proteolytic sheddase that is responsible for the cleavage of several membrane-bound molecules. We report that TACE cleaves neuregulin-1 (NRG1) type III in the epidermal growth factor domain, probably inactivating it (as assessed by deficient activation of the phosphatidylinositol-3-OH kinase pathway), and thereby negatively regulating peripheral nervous system (PNS) myelination. Lentivirus-mediated knockdown of TACE in vitro in dorsal root ganglia neurons accelerates the onset of myelination and results in hypermyelination. In agreement, motor neurons of conditional knockout mice lacking TACE specifically in these cells are significantly hypermyelinated, and small-caliber fibers are aberrantly myelinated. Further, reduced TACE activity rescues hypomyelination in NRG1 type III haploinsufficient mice in vivo. We also show that the inhibitory effect of TACE is neuron-autonomous, as Schwann cells lacking TACE elaborate myelin of normal thickness. Thus, TACE is a modulator of NRG1 type III activity and is a negative regulator of myelination in the PNS.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21666671 PMCID: PMC3291894 DOI: 10.1038/nn.2849
Source DB: PubMed Journal: Nat Neurosci ISSN: 1097-6256 Impact factor: 24.884